# Interest of Oxytocin as an Adjuvant Treatment of Psycho-educational Measures in Challenging Behaviors in Children With Autism Spectrum Disorders and Moderate to Severe Intellectual Disability: Feasibility and Safety Study.

> **NCT05864508** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University Hospital, Toulouse** · enrollment: 30 (estimated)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

- **DRUG:** Oxytocin nasal spray

## Key facts

- **NCT ID:** NCT05864508
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-07
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05864508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05864508, "Interest of Oxytocin as an Adjuvant Treatment of Psycho-educational Measures in Challenging Behaviors in Children With Autism Spectrum Disorders and Moderate to Severe Intellectual Disability: Feasibility and Safety Study.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05864508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*